Catalyst Wire Dossier Catalyst Wire Dossier

BAX 930

recombinant human ADAMTS13 · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAX 930, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]

See pricing